company background image
600867 logo

Tonghua Dongbao Pharmaceutical SHSE:600867 Stock Report

Last Price

CN¥9.89

Market Cap

CN¥19.7b

7D

-5.1%

1Y

-16.9%

Updated

27 Mar, 2024

Data

Company Financials +

Tonghua Dongbao Pharmaceutical Co., Ltd.

SHSE:600867 Stock Report

Market Cap: CN¥19.7b

600867 Stock Overview

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

600867 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Tonghua Dongbao Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tonghua Dongbao Pharmaceutical
Historical stock prices
Current Share PriceCN¥9.89
52 Week HighCN¥12.73
52 Week LowCN¥8.40
Beta0.21
1 Month Change-3.23%
3 Month Change-7.48%
1 Year Change-16.89%
3 Year Change-20.31%
5 Year Change-43.65%
Change since IPO1,040.21%

Recent News & Updates

Recent updates

Shareholder Returns

600867CN PharmaceuticalsCN Market
7D-5.1%-3.4%-2.2%
1Y-16.9%-11.4%-14.8%

Return vs Industry: 600867 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 600867 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 600867's price volatile compared to industry and market?
600867 volatility
600867 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 600867 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600867's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19853,054Sheng Leng Chunhttps://www.thdb.com

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices.

Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamentals Summary

How do Tonghua Dongbao Pharmaceutical's earnings and revenue compare to its market cap?
600867 fundamental statistics
Market capCN¥19.74b
Earnings (TTM)CN¥1.18b
Revenue (TTM)CN¥3.09b

16.6x

P/E Ratio

6.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600867 income statement (TTM)
RevenueCN¥3.09b
Cost of RevenueCN¥0
Gross ProfitCN¥3.09b
Other ExpensesCN¥1.92b
EarningsCN¥1.18b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Mar 29, 2024

Earnings per share (EPS)0.59
Gross Margin100.00%
Net Profit Margin38.07%
Debt/Equity Ratio2.2%

How did 600867 perform over the long term?

See historical performance and comparison

Dividends

5.1%

Current Dividend Yield

53%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.